MDIT
MEDITE CANCER DIAGNOSTICS by Medite Cancer Diagnostics, Inc. (MDIT)
$
00About MEDITE CANCER DIAGNOSTICS by Medite Cancer Diagnostics, Inc. (MDIT)
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. The firm specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland. The company was founded in December 1998 and is headquartered in Orlando, FL.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
94
P/E ratio
--
MEDITE CANCER DIAGNOSTICS by Medite Cancer Diagnostics, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
94
P/E ratio
--